Nanoparticles, immunomodulation and vaccine delivery

Sue Dong Xiang, Martina Fuchsberger, Tanya De Lourdes Karlson, Charles Linton Hardy, Cordelia Selomulya, Magdalena Plebanski

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

Interest in nanoparticles and their use as vaccine carriers and adjuvants has greatly increased in recent times. However, despite current intense research in this field, the ways in which the immune system responds to nanoscale particulates are still being defined. This chapter will review the physical and chemical characteristics of nanoparticles 1-1000 nm in diameter, considering size, shape, surface charge and chemistry, and their effects on the immune system, including drainage to the lymph nodes (LNs), uptake by antigen-presenting cells (APCs) and the triggering of intracellular signalling pathways. We examine how particle size affects nanoparticle uptake by the key innate stimulators of the immune system, i.e., dendritic cells (DCs), and how nanoparticles modulate DCs and the induction of multiple arms of the immune response, including antibody production and CD4 and CD8 T cell responses via conventional and cross-priming pathways. We further discuss how inert nanoparticles, which by themselves may not necessarily promote the significant inflammation usually associated with adjuvants, can nevertheless induce powerful immunity, suggesting nanotechnology has outstanding potential to deliver safe synthetic vaccines against today s major diseases such as cancer and malaria. Biodegradable or biocompatible nanoparticles, such as polymeric particles, chitosan, polystyrene, gold/silver particles and magnetic/metallic particles, are discussed in relation to the induction of immune responses and vaccine formulations. An indepth understanding of how nanoparticles physicochemically modulate the immune system supports the rational development of nanoparticle-based vaccines, as well as safe nanoparticulate drug delivery systems.
Original languageEnglish
Title of host publicationHandbook of Immunological Properties of Engineered Nanomaterials
EditorsMarina A Dobrovolskaia, Scott E McNeil
Place of PublicationUSA
PublisherWorld Scientific Publishing
Pages449 - 476
Number of pages28
ISBN (Print)9789814390255
DOIs
Publication statusPublished - 2013

Cite this

Xiang, S. D., Fuchsberger, M., Karlson, T. D. L., Hardy, C. L., Selomulya, C., & Plebanski, M. (2013). Nanoparticles, immunomodulation and vaccine delivery. In M. A. Dobrovolskaia, & S. E. McNeil (Eds.), Handbook of Immunological Properties of Engineered Nanomaterials (pp. 449 - 476). USA: World Scientific Publishing. https://doi.org/10.1142/9789814390262_0015
Xiang, Sue Dong ; Fuchsberger, Martina ; Karlson, Tanya De Lourdes ; Hardy, Charles Linton ; Selomulya, Cordelia ; Plebanski, Magdalena. / Nanoparticles, immunomodulation and vaccine delivery. Handbook of Immunological Properties of Engineered Nanomaterials. editor / Marina A Dobrovolskaia ; Scott E McNeil. USA : World Scientific Publishing, 2013. pp. 449 - 476
@inbook{e5709119488945f68a9f1922df05272d,
title = "Nanoparticles, immunomodulation and vaccine delivery",
abstract = "Interest in nanoparticles and their use as vaccine carriers and adjuvants has greatly increased in recent times. However, despite current intense research in this field, the ways in which the immune system responds to nanoscale particulates are still being defined. This chapter will review the physical and chemical characteristics of nanoparticles 1-1000 nm in diameter, considering size, shape, surface charge and chemistry, and their effects on the immune system, including drainage to the lymph nodes (LNs), uptake by antigen-presenting cells (APCs) and the triggering of intracellular signalling pathways. We examine how particle size affects nanoparticle uptake by the key innate stimulators of the immune system, i.e., dendritic cells (DCs), and how nanoparticles modulate DCs and the induction of multiple arms of the immune response, including antibody production and CD4 and CD8 T cell responses via conventional and cross-priming pathways. We further discuss how inert nanoparticles, which by themselves may not necessarily promote the significant inflammation usually associated with adjuvants, can nevertheless induce powerful immunity, suggesting nanotechnology has outstanding potential to deliver safe synthetic vaccines against today s major diseases such as cancer and malaria. Biodegradable or biocompatible nanoparticles, such as polymeric particles, chitosan, polystyrene, gold/silver particles and magnetic/metallic particles, are discussed in relation to the induction of immune responses and vaccine formulations. An indepth understanding of how nanoparticles physicochemically modulate the immune system supports the rational development of nanoparticle-based vaccines, as well as safe nanoparticulate drug delivery systems.",
author = "Xiang, {Sue Dong} and Martina Fuchsberger and Karlson, {Tanya De Lourdes} and Hardy, {Charles Linton} and Cordelia Selomulya and Magdalena Plebanski",
year = "2013",
doi = "10.1142/9789814390262_0015",
language = "English",
isbn = "9789814390255",
pages = "449 -- 476",
editor = "Dobrovolskaia, {Marina A} and McNeil, {Scott E}",
booktitle = "Handbook of Immunological Properties of Engineered Nanomaterials",
publisher = "World Scientific Publishing",
address = "Singapore",

}

Xiang, SD, Fuchsberger, M, Karlson, TDL, Hardy, CL, Selomulya, C & Plebanski, M 2013, Nanoparticles, immunomodulation and vaccine delivery. in MA Dobrovolskaia & SE McNeil (eds), Handbook of Immunological Properties of Engineered Nanomaterials. World Scientific Publishing, USA, pp. 449 - 476. https://doi.org/10.1142/9789814390262_0015

Nanoparticles, immunomodulation and vaccine delivery. / Xiang, Sue Dong; Fuchsberger, Martina; Karlson, Tanya De Lourdes; Hardy, Charles Linton; Selomulya, Cordelia; Plebanski, Magdalena.

Handbook of Immunological Properties of Engineered Nanomaterials. ed. / Marina A Dobrovolskaia; Scott E McNeil. USA : World Scientific Publishing, 2013. p. 449 - 476.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Nanoparticles, immunomodulation and vaccine delivery

AU - Xiang, Sue Dong

AU - Fuchsberger, Martina

AU - Karlson, Tanya De Lourdes

AU - Hardy, Charles Linton

AU - Selomulya, Cordelia

AU - Plebanski, Magdalena

PY - 2013

Y1 - 2013

N2 - Interest in nanoparticles and their use as vaccine carriers and adjuvants has greatly increased in recent times. However, despite current intense research in this field, the ways in which the immune system responds to nanoscale particulates are still being defined. This chapter will review the physical and chemical characteristics of nanoparticles 1-1000 nm in diameter, considering size, shape, surface charge and chemistry, and their effects on the immune system, including drainage to the lymph nodes (LNs), uptake by antigen-presenting cells (APCs) and the triggering of intracellular signalling pathways. We examine how particle size affects nanoparticle uptake by the key innate stimulators of the immune system, i.e., dendritic cells (DCs), and how nanoparticles modulate DCs and the induction of multiple arms of the immune response, including antibody production and CD4 and CD8 T cell responses via conventional and cross-priming pathways. We further discuss how inert nanoparticles, which by themselves may not necessarily promote the significant inflammation usually associated with adjuvants, can nevertheless induce powerful immunity, suggesting nanotechnology has outstanding potential to deliver safe synthetic vaccines against today s major diseases such as cancer and malaria. Biodegradable or biocompatible nanoparticles, such as polymeric particles, chitosan, polystyrene, gold/silver particles and magnetic/metallic particles, are discussed in relation to the induction of immune responses and vaccine formulations. An indepth understanding of how nanoparticles physicochemically modulate the immune system supports the rational development of nanoparticle-based vaccines, as well as safe nanoparticulate drug delivery systems.

AB - Interest in nanoparticles and their use as vaccine carriers and adjuvants has greatly increased in recent times. However, despite current intense research in this field, the ways in which the immune system responds to nanoscale particulates are still being defined. This chapter will review the physical and chemical characteristics of nanoparticles 1-1000 nm in diameter, considering size, shape, surface charge and chemistry, and their effects on the immune system, including drainage to the lymph nodes (LNs), uptake by antigen-presenting cells (APCs) and the triggering of intracellular signalling pathways. We examine how particle size affects nanoparticle uptake by the key innate stimulators of the immune system, i.e., dendritic cells (DCs), and how nanoparticles modulate DCs and the induction of multiple arms of the immune response, including antibody production and CD4 and CD8 T cell responses via conventional and cross-priming pathways. We further discuss how inert nanoparticles, which by themselves may not necessarily promote the significant inflammation usually associated with adjuvants, can nevertheless induce powerful immunity, suggesting nanotechnology has outstanding potential to deliver safe synthetic vaccines against today s major diseases such as cancer and malaria. Biodegradable or biocompatible nanoparticles, such as polymeric particles, chitosan, polystyrene, gold/silver particles and magnetic/metallic particles, are discussed in relation to the induction of immune responses and vaccine formulations. An indepth understanding of how nanoparticles physicochemically modulate the immune system supports the rational development of nanoparticle-based vaccines, as well as safe nanoparticulate drug delivery systems.

UR - http://www.worldscientific.com/doi/pdf/10.1142/9789814390262_0015

U2 - 10.1142/9789814390262_0015

DO - 10.1142/9789814390262_0015

M3 - Chapter (Book)

SN - 9789814390255

SP - 449

EP - 476

BT - Handbook of Immunological Properties of Engineered Nanomaterials

A2 - Dobrovolskaia, Marina A

A2 - McNeil, Scott E

PB - World Scientific Publishing

CY - USA

ER -

Xiang SD, Fuchsberger M, Karlson TDL, Hardy CL, Selomulya C, Plebanski M. Nanoparticles, immunomodulation and vaccine delivery. In Dobrovolskaia MA, McNeil SE, editors, Handbook of Immunological Properties of Engineered Nanomaterials. USA: World Scientific Publishing. 2013. p. 449 - 476 https://doi.org/10.1142/9789814390262_0015